Overview
AHK-Cu (Ala-His-Lys-Cu²⁺) is a copper-binding tripeptide that shares structural similarities with the well-known regenerative peptide GHK-Cu (Gly-His-Lys-Cu²⁺), differing by a single amino acid substitution at the N-terminal position. This seemingly minor change significantly alters the peptide's binding affinity, tissue distribution, and biological activity profile, making AHK-Cu a distinct therapeutic entity worthy of independent investigation.
Research into copper peptides accelerated following the landmark work of Dr. Loren Pickart in the 1970s, who identified copper-binding peptides as key mediators of tissue remodeling and wound repair. While GHK-Cu received the majority of research attention, AHK-Cu has emerged as a complementary agent with particular promise in dermatological applications, especially hair follicle stimulation and dermal papilla cell activation.
The copper ion in AHK-Cu serves as a catalytic cofactor for multiple enzymes involved in connective tissue synthesis, including lysyl oxidase (collagen crosslinking), superoxide dismutase (antioxidant defense), and tyrosinase (melanin synthesis). The tripeptide scaffold provides targeted delivery of bioavailable copper to cells expressing appropriate receptors, avoiding the toxicity associated with free copper ions.
AHK-Cu has gained commercial popularity in advanced skincare formulations and hair restoration protocols, though rigorous clinical trial data remains limited compared to its more established cousin GHK-Cu.
Quick facts
- Mechanism
- Copper-delivery tripeptide activating dermal regeneration
- Primary use
- Wound Healing & Hair Growth
- Evidence
- moderate
- FDA
- Not approved
- Route
- Topical application or mesotherapy injection
- Typical results
- Improved wound healing and hair follicle stimulation observed in cell culture and animal models within 2–8 weeks
Chemical information
AHK-Cu (C₁₅H₂₄ClCuN₆O₄) is a regeneration compound with a molecular weight of 451.39 g/mol. Its structural characteristics underpin its biological activity in tissue repair and regeneration.
How AHK-Cu works
AHK-Cu delivers bioavailable copper to dermal papilla cells and fibroblasts through receptor-mediated uptake, where the copper ion activates metalloproteases and growth factor cascades essential for tissue remodeling. The peptide upregulates Wnt/β-catenin signaling in hair follicle stem cells, promoting the transition from telogen (resting) to anagen (growth) phase.
At the molecular level, AHK-Cu activates dermal papilla cells through stimulation of extracellular signal-regulated kinase (ERK) and Akt signaling pathways. This leads to increased proliferation of hair follicle keratinocytes and upregulation of vascular endothelial growth factor (VEGF), improving blood supply to the follicular unit. Studies have demonstrated that AHK-Cu increases dermal papilla cell viability by up to 200% at optimal concentrations.
The copper component serves as a cofactor for lysyl oxidase, an enzyme critical for collagen and elastin crosslinking in the extracellular matrix. By providing targeted copper delivery, AHK-Cu enhances the structural integrity of newly formed connective tissue without the oxidative stress associated with free copper ions. The peptide also induces superoxide dismutase (SOD) expression, providing antioxidant protection during the wound healing process.
In dermal fibroblasts, AHK-Cu stimulates the production of decorin, a proteoglycan that regulates TGF-β activity and controls collagen fibril assembly. This results in more organized collagen deposition and reduced scar formation compared to unregulated wound healing. The peptide also modulates matrix metalloproteinase (MMP) activity to facilitate controlled tissue remodeling.
- Wnt/β-catenin activation: Stimulates hair follicle stem cell proliferation and anagen induction
- Copper cofactor delivery: Provides bioavailable Cu²⁺ for lysyl oxidase and SOD activation
- ERK/Akt signaling: Activates proliferation and survival pathways in dermal papilla cells
- VEGF upregulation: Improves vascularization of hair follicles and wound sites
- ECM remodeling: Enhances decorin production for organized collagen assembly
Pharmacokinetics
| Parameter | Value | Significance |
|---|---|---|
| Molecular Weight | 451.39 g/mol | Small enough for topical penetration with appropriate formulation |
| Copper Binding Affinity | Kd ~10⁻¹¹ M | High-affinity copper chelation prevents free copper toxicity |
| Stability | pH 5.0–6.5 optimal | Most stable in slightly acidic formulations matching skin pH |
| Penetration | Stratum corneum permeable | Effective via topical application without injection requirement |
Dosing & administration
AHK-Cu dosing varies by indication and individual factors. No FDA-approved dosing exists for this compound; protocols in the literature derive from limited clinical or preclinical data and practitioner experience.
Any use should be conducted under qualified medical supervision with appropriate monitoring of safety markers.
Important: These dosing ranges are not FDA-approved. Any use should be under qualified medical supervision.
Side effects & safety
Safety data for AHK-Cu is primarily derived from preclinical studies and limited human data. Long-term effects in humans remain incompletely characterized.
Common
- • Enhanced dermal papilla cell proliferation and hair follicle stimulation
- • Accelerated wound healing with reduced scar formation
- • Increased collagen and elastin synthesis in dermal tissue
- • Antioxidant protection through SOD upregulation
- • Improved skin elasticity and thickness with topical application
- • Complementary effects when combined with GHK-Cu
Serious / potential risks
- • Mild skin irritation possible at high concentrations
- • Rare copper sensitivity reactions in susceptible individuals
- • Temporary skin discoloration at injection sites
- • Should not be used with Wilson's disease or copper metabolism disorders
- • Limited long-term safety data for injectable administration
Drug interactions
| Medication | Interaction | Recommendation |
|---|---|---|
| Minoxidil | Potentially synergistic | Combination protocols show enhanced hair regrowth; can be used together |
| Retinoids (Tretinoin) | Enhanced penetration | Retinoids increase skin permeability; reduce AHK-Cu concentration to avoid irritation |
| Copper chelators (Penicillamine) | Antagonistic | Chelators remove copper from the peptide complex, negating therapeutic effects |
| Zinc supplements (high dose) | Competitive absorption | High zinc may reduce copper bioavailability; space administration |
Storage & handling
Lyophilized (powder)
- • Store at -20°C to 4°C (freezer or refrigerator)
- • Protect from light and moisture
- • Stable for 12–24 months when stored properly
- • Keep in original sealed container until reconstitution
Reconstituted solution
- • Refrigerate at 2–8°C after reconstitution
- • Use bacteriostatic water for multi-dose reconstitution
- • Typical stability: 14–28 days refrigerated
- • Do not freeze reconstituted solution
Cost & availability
| Source | Cost | Notes |
|---|---|---|
| Research suppliers | Varies widely | Quality and purity vary significantly between sources |
| Compounding pharmacies | Prescription required | Higher quality assurance and purity testing |
The bottom line
AHK-Cu is a regeneration compound with research interest in wound healing, hair growth, skin rejuvenation. While preclinical evidence is encouraging, it remains investigational and is not FDA-approved. Any use should be under qualified medical supervision.
Best for
- • Researchers studying tissue repair and regeneration
- • Individuals interested in wound healing under medical guidance
Not for
- • Self-administration without medical supervision
- • Pregnant or breastfeeding individuals
- • Individuals with contraindicated conditions
Related compounds
Frequently asked questions
References
- [1] Pyo HK, Yoo HG, Won CH, et al.. The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res (2014). doi: 10.1007/s12272-013-0075-x PMID: 23543636
- [2] Kang YA, Shin HD, Park HM, et al.. Copper-GHK increases VEGF expression in dermal papilla cells. J Cosmet Sci (2009). PMID: 19728789
- [3] Pickart L, Vasquez-Soltero JM, Margolina A.. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int (2015). doi: 10.1155/2015/648108 PMID: 25866791
- [4] Lü ZR, Park TH, Lee ES, et al.. Effect of the tripeptide AHK on decorin expression and wound healing. Peptides (2007). doi: 10.1016/j.peptides.2007.08.001 PMID: 17904684